相关实验视频

Updated: Jul 4, 2025

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

利用多来源数据,为霍奇金淋巴瘤患者提供个性化护理

Susan K Parsons¹, Angie Mae Rodday², Jenica N Upshaw³

¹Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, United States of America; Division of Hematology/Oncology, Tufts Medical Center, Boston, MA, United States of America.

|January 30, 2024

概括

这项研究详细介绍了创建霍奇金淋巴瘤患者数据库和决策模型的方法. 这些工具旨在指导治疗选择,并预测长期风险,以改善患者的治疗结果.

科学领域:

血液学血液学血液学
在瘤学瘤学.
数据科学数据科学数据科学

背景情况:

霍奇金淋巴瘤是一种可治愈的癌症,主要影响年轻人.
治疗共识仍然难以捉摸,关于放射治疗和不断发展的新疗法正在进行辩论.
在不同的治疗方法中存在不同的长期风险.

研究的目的:

使用个体患者数据开发霍奇金淋巴瘤的临床决策模型.
为医疗保健提供者,患者和护理人员在治疗决策中提供指导.
为了估计累积治疗暴露的晚期影响的风险.

主要方法:

在2018年建立了HoLISTIC联盟,整合了疾病和方法专家.
使用数据科学原则创建了过去20年个人患者数据的主数据库.
采用临床预测工具,多状态模型和模拟建模,用于决策和风险评估.

主要成果:

一个全面的主数据库的霍奇金淋巴瘤患者数据已经编制.
已经开发了临床决策的方法方法,包括预测和多状态模型.
模拟建模是用来估计基于治疗史的晚期效应.

结论:

开发的数据库和临床决策工具为管理霍奇金淋巴瘤提供了一个动态的方法.
预计这些资源将随着新数据的发展而发展,改善个性化治疗策略.
霍利斯蒂克联盟的工作促进了知情决策,以改善患者护理和结果.

关键词:

霍奇金淋巴瘤是一种霍奇金淋巴瘤.多状态建模多状态建模结果的结果.预测建模的预测模型.

更多相关视频

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...